TechFDA Approves New Alzheimer's Drug, Bringing Hope of Slowing Disease for US Patients The US Food and Drug Administration (FDA) gave a green light to Eli Lilly's Kisunla, a new Alzheimer's drug that slightly delays the disease's progression.by Inno Flores
HealthNew Neuron Production in Mice Found Effective in Restoring Memories in Alzheimer’s Diseaseby Thea Felicity
HealthPromising Alzheimer’s Treatment Found on Experimental Cancer Drug Upon Testing on Miceby Isaiah Richard
Healthy Living/WellnessAlzheimer's Drug Donepezil Could Keep Late Stage Sufferers Out Of Nursing Homesby Katherine Derla
Healthy Living/WellnessAlzheimer's blood test to predict onset of dementia may be ready in two yearsby Anne Francis